In 2012, the United States Preventive Service Task Force (USPSTF) advocated that urologists not routinely screen men without symptoms of prostate cancer using the prostate specific antigen (PSA) test. Their argument was that the benefits of PSA testing in men may not justify the cost of implementing PSA as a screening tool, and they had concerns that the harms of PSA outweigh the benefits.
However, I did a study, which was published in the journal Urologic Oncology in August, that compared the results of 2,495 of my patients with prostate cancer who underwent surgery to remove their prostate gland using SMART, a minimally invasive, robot-assisted procedure I modified.
Men as young as 40 can get prostate cancer and it is often more aggressive in younger men.
